---
title: "Iambic Therapeutics Names William Rastetter Board Chairperson"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305674940.md"
description: "Iambic Therapeutics appointed William Rastetter as Board Chairperson, leveraging his prior experience as CEO of IDEC Pharmaceuticals and Executive Chairman of Biogen Idec. Additionally, Samit Hirawat joined the board in August 2026, bringing expertise from his tenure as Chief Medical Officer at Bristol Myers Squibb. Sunny Chang was also promoted to General Counsel."
datetime: "2026-11-16T13:05:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305674940.md)
  - [en](https://longbridge.com/en/news/305674940.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305674940.md)
generator: "portal-rs"
---

# Iambic Therapeutics Names William Rastetter Board Chairperson

-   Iambic Therapeutics named William Rastetter board chair; he previously served as IDEC Pharmaceuticals CEO and Biogen Idec executive chairman. \* Samit Hirawat joined the board in August 2026. \* Hirawat served as Bristol Myers Squibb’s chief medical officer and head of global drug development from 2019 to 2025. \* Sunny Chang was promoted to general counsel. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iambic Therapeutics Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9877949) on November 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [IAM.US](https://longbridge.com/en/quote/IAM.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

- [Iambic Therapeutics, Inc. GAAP EPS of -$8.52 misses by $7.75, revenue of $11.4M beats by $3.11M](https://longbridge.com/en/news/305698417.md)
- [IAM: Pipeline progress and $455M pro forma cash position support planned 2027 milestones](https://longbridge.com/en/news/305676390.md)
- [Bank of America Names 2 'Strong Buy' Stocks With 60%+ Upside](https://longbridge.com/en/news/305294459.md)
- [Iambic CEO Joins AI Drug Discovery Panel at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/304855723.md)
- [Jim Cramer says Nvidia’s leadership shake-up won’t derail the AI trade](https://longbridge.com/en/news/305736094.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**